Loading…
Multiple sclerosis: immunomodulators, education, and self-injection
One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients performed self-injection. For both modes of inject...
Saved in:
Published in: | Revue neurologique 2007-12, Vol.163 (12), p.1209 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | fre |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients performed self-injection. For both modes of injection studied (subcutaneous or intramuscular), self-injection was significantly more frequent among patients who were received training and followed via telephone assistance conducted by a nurse with specialized training in MS. Our study demonstrated that waste disposal (needles), especially among patients performing self-injections, remains an important problem. Efforts must be taken concerning this important healthcare issue. |
---|---|
ISSN: | 0035-3787 |
DOI: | 10.1016/S0035-3787(07)78405-9 |